BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 36032133)

  • 21. [Comparative Analysis of Primary and Reactivated EB Virus Infection Associated Hemophagocytic Lymphohistiocytosis].
    Liu JH; Liu W; Li YG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):575-580. PubMed ID: 37096536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Children with lymphoma presenting with hemophagocytic lymphohistiocytosis.
    Aksu T; Bayhan T; Gülhan B; Çakmakcı S; Oğuz AS; Yaralı N; Özbek NY; İlhan İ
    Turk J Pediatr; 2020; 62(2):284-288. PubMed ID: 32419422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Significance of Plasma Soluble MICB in Children With EBV-associated Hemophagocytic Lymphohistiocytosis.
    Wei A; Zhang L; Ma H; Cui L; Zhang Q; Wang D; Chen S; Du J; Zhao X; Wang T; Zhang R; Zheng H; Li Z
    J Pediatr Hematol Oncol; 2023 May; 45(4):e446-e454. PubMed ID: 36898046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spectrum of Epstein-Barr virus-associated T-cell lymphoproliferative disorder in adolescents and young adults in Taiwan.
    Wang RC; Chang ST; Hsieh YC; Huang WT; Hsu JD; Tseng CE; Wang MC; Hwang WS; Wang J; Chuang SS
    Int J Clin Exp Pathol; 2014; 7(5):2430-7. PubMed ID: 24966953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prospective quality improvement initiative in adult hemophagocytic lymphohistiocytosis to improve testing and a framework to facilitate trigger identification and mitigate hemorrhage from retrospective analysis.
    Merrill SA; Naik R; Streiff MB; Shanbhag S; Lanzkron S; Braunstein EM; Moliterno AM; Brodsky RA
    Medicine (Baltimore); 2018 Aug; 97(31):e11579. PubMed ID: 30075527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment outcomes and prognostic analysis of 61 Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis].
    Zeng X; Wei N; Wang Y; Wang J; Zhang J; Wu L; Huang W; Gao Z; Pei R; Chen J; Jin Z; Wang Z
    Zhonghua Xue Ye Xue Za Zhi; 2015 Jun; 36(6):507-10. PubMed ID: 26134018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Los Angeles County.
    Kelesidis T; Humphries R; Terashita D; Eshaghian S; Territo MC; Said J; Lewinski M; Currier JS; Pegues D
    J Med Virol; 2012 May; 84(5):777-85. PubMed ID: 22431026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunologic difference between hypersensitivity to mosquito bite and hemophagocytic lymphohistiocytosis associated with Epstein-Barr virus infection.
    Lee WI; Lin JJ; Hsieh MY; Lin SJ; Jaing TH; Chen SH; Hung IJ; Yang CP; Chen CJ; Huang YC; Li SP; Huang JL
    PLoS One; 2013; 8(10):e76711. PubMed ID: 24204658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA-mismatched GPBSC infusion therapy in refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis: an observational study from a single center.
    Song Y; Wang J; Wang Y; Wang Z
    Stem Cell Res Ther; 2020 Jul; 11(1):265. PubMed ID: 32611452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Characteristic and prognosis of patients with non-EBV infection-associated hemophagocytic lymphohistiocytosis].
    You YH; Wang JS; Wang Z
    Zhonghua Xue Ye Xue Za Zhi; 2022 Feb; 43(2):128-133. PubMed ID: 35381673
    [No Abstract]   [Full Text] [Related]  

  • 31. Spectrum of neuroradiological manifestations in primary hemophagocytic lymphohistiocytosis: a comparative study of EBV-induced versus non-EBV-induced forms in 75 genetically confirmed pediatric cases.
    Charpentier H; Roux CJ; Leroux P; Briand C; Levy R; Dangouloff-Ros V; Desguerre I; Neven B; Moshous D; Boddaert N
    Eur Radiol; 2023 Oct; 33(10):7149-7159. PubMed ID: 37171488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Possible Concomitant Aggressive NK Cell Leukemia and EBV-positive T-cell lymphoma; Using the online beta version of WHO-HAEM5 and videoconferencing software to make diagnoses accessible in an emerging economy.
    Dayton VJ; Hoang Thien D; Xinh PT; Arries C; Sang NN; Linh NNN; Lien NP; Dung PC
    Diagn Pathol; 2023 Oct; 18(1):111. PubMed ID: 37803436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis-a dangerous disease.
    Jin Z; Wang Y; Wei N; Wang Z
    Ann Hematol; 2020 Jul; 99(7):1575-1581. PubMed ID: 32500223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The ambiguous boundary between EBV-related hemophagocytic lymphohistiocytosis and systemic EBV-driven T cell lymphoproliferative disorder.
    Smith MC; Cohen DN; Greig B; Yenamandra A; Vnencak-Jones C; Thompson MA; Kim AS
    Int J Clin Exp Pathol; 2014; 7(9):5738-49. PubMed ID: 25337215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a screening score for Hemophagocytic Lymphohistiocytosis among pediatric patients with acute infection of Epstein-Barr virus.
    Li X; Yan H; Xiao Z; Luo T; Xie L; Yang Y; Gong L; Tang Z; Huang J; Zhang X; Zheng M; Yao Z; Zang P; Zhu D; Lu X
    Front Immunol; 2022; 13():981251. PubMed ID: 36172365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epstein-Barr Virus-Positive Lymphoma-Associated Hemophagocytic Syndrome: A Retrospective, Single-Center Study of 51 Patients.
    Zhao A; Yang J; Li M; Li L; Gan X; Wang J; Li H; Shen K; Yang Y; Niu T
    Front Immunol; 2022; 13():882589. PubMed ID: 35479073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epstein barr virus hemophagocytic lymphohistiocytosis related to rituximab use and immunopathogenetic insights.
    Papageorgiou SG; Tsiodras S; Siakallis G; Bazani E; Spathis A; Poulakou G; Korkolopoulou P; Panayiotides I; Pappa V
    Pathol Res Pract; 2016 Dec; 212(12):1194-1198. PubMed ID: 28340951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
    Sato E; Ohga S; Kuroda H; Yoshiba F; Nishimura M; Nagasawa M; Inoue M; Kawa K
    Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogenesis and mechanism of disease progression from hemophagocytic lymphohistiocytosis to Epstein-Barr virus-associated T-cell lymphoma: nuclear factor-kappa B pathway as a potential therapeutic target.
    Chuang HC; Lay JD; Hsieh WC; Su IJ
    Cancer Sci; 2007 Sep; 98(9):1281-7. PubMed ID: 17627615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epstein-Barr Virus-Related Hemophagocytic Lymphohistiocytosis with Central Nervous System Symptoms.
    Sakaguchi M; Nagata Y; Terasaki Y; Takeyoshi A; Yasuda S; Honma S; Kinoshita R; Marumo A; Asayama T; Yui S; Wakita S; Okamoto M; Kajimoto Y; Inokuchi K; Yamaguchi H
    J Nippon Med Sch; 2023 Mar; 90(1):126-135. PubMed ID: 36436914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.